Verapamil-Potassium Cardioplegia: A Two-Year Experience with 470 Patients

AUTOR(ES)
RESUMO

This prospective clinical study in cardiac surgery involves a 2-year experience with verapamil-potassium cardioplegia in 470 patients. Protective benefits, associated with calcium channel blockers during cellular ischemia, have increased their utilization in cardioplegic solutions during open-heart surgery.

Documentos Relacionados